Check-Cap (NASDAQ:MBAI) Shares Down 1.5% – Should You Sell?

Check-Cap Ltd (NASDAQ:MBAI) shares dropped 1.5% during trading on Wednesday . The stock traded as low as $1.00 and last traded at $1.01. Approximately 7,137 shares were traded during trading, a decline of 90% from the average daily volume of 69,051 shares. The stock had previously closed at $1.0250.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Check-Cap in a research note on Tuesday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Check-Cap has an average rating of “Sell”.

Check-Cap Stock Performance

The company has a market cap of $8.02 million, a PE ratio of -0.55 and a beta of 0.65. The firm’s fifty day moving average price is $1.38.

Check-Cap Company Profile

Check-Cap Ltd. (NASDAQ: MBAI) is an Israel-based medical technology company focused on non-invasive screening solutions for colorectal cancer. The company develops an ingestible imaging capsule and associated detection system intended to provide a patient-friendly alternative to traditional colonoscopy and CT colonography for colorectal screening and polyp detection.

Check-Cap’s technology centers on a swallowable capsule that acquires images of the colon as it traverses the gastrointestinal tract; external detectors capture the transmitted signals and software reconstructs images for clinical review.